| Standard not met | Reason | Action being taken by the Pharmacy | By when | Notification By Pharmacy Improvements Made |
|---|---|---|---|---|
| 1.1 | The pharmacy frequently sells codeine linctus. But it does not have adequate systems in place to identify and manage the risks of abuse, overuse or misuse. |
Conditions are imposed to prevent the sale and supply of codeine linctus. |
02/09/2020 | |
| 1.2 | The pharmacy does not monitor or review the sales of medicines that are liable to misuse or abuse. So it cannot provide assurance that sales are appropriately controlled. |
Reviewed and added new SOP for sale of medicines. All counter staff to sign. List of drugs of abuse given to staff, so sales directed to pharmacist only. |
02/09/2020 | 08/09/2020 |
| 2.2 | The medicines counter assistants do not have enough knowledge about the correct use of some of the medicines they sell. |
Staff read new SOP and list of drugs of abuse given to staff. Counter staff will read and go over OTC book for refresher and pharmacist will test them on their knowledge. |
02/09/2020 | 08/09/2020 |
| 2.3 | The pharmacist does not adequately supervise sales of over-the-counter medicines. So the pharmacy cannot provide assurance that they are being used safely. |
Staff are to make pharmacist aware on all sales of OTC but products of abuse are solely for pharmacist on duty to exercise professional knowledge and judgement. |
02/09/2020 | 08/09/2020 |
| 4.2 | The pharmacy sells large amounts of codeine linctus without making appropriate checks to prevent misuse. |
Conditions are imposed to prevent the sale and supply of codeine linctus. |
02/09/2020 |
Pharmacy inspections
Inspection reports and learning from inspections